Outside IR35 Pharma Contract Jobs

The pharmaceutical sector is a major and specialist contracting market in the UK, engaging professionals across clinical development, regulatory affairs, quality assurance, pharmacovigilance, medical writing, manufacturing, supply chain, and commercial functions on a contract basis. The sector's project-intensive drug development pipeline, combined with the demanding regulatory environment overseen by the MHRA and EMA, creates consistent demand for specialist contractor expertise across the full drug development and commercialisation lifecycle. The UK pharmaceutical contracting market is concentrated around clusters in London, the Thames Valley, the East of England, and Scotland, where major pharmaceutical companies and contract research organisations maintain significant operations.

The regulatory framework is the defining feature of pharmaceutical contracting. Contractors working in drug development, clinical operations, or manufacturing must be thoroughly familiar with GxP standards relevant to their discipline, including GCP for clinical development, GMP for manufacturing, GLP for non-clinical studies, and the specific ICH guidelines that govern pharmaceutical development and submission. Pharmacovigilance contractors need knowledge of EU GVP modules and MHRA pharmacovigilance requirements, including Individual Case Safety Report processing and aggregate reporting. Regulatory affairs contractors need expertise in CTD submission formats, MHRA and EMA registration procedures, and variation management. Manufacturing contractors in pharmaceutical environments need familiarity with MHRA inspection requirements and the specific quality systems frameworks that govern pharmaceutical manufacturing operations.

Pharmaceutical contracting in the UK is underpinned by a large and globally connected industry with significant domestic R&D investment, particularly in biologics, oncology, and rare disease programmes. Demand has been sustained by the strong clinical trial pipeline, continued investment in pharmaceutical manufacturing capacity, and the regulatory change activity driven by Brexit's impact on UK marketing authorisation arrangements. The growth of cell and gene therapy manufacturing is creating new specialist contractor demand in novel manufacturing processes, while digital health and real-world evidence programmes are generating demand for data and technology contractors with pharmaceutical sector knowledge. Rates across pharmaceutical contracting are among the strongest in the life sciences sector, reflecting the specialist regulatory knowledge required.

IR35 is UK tax legislation that determines whether a contractor is genuinely self-employed or working in a manner that resembles employment. When a contract is classified as outside IR35, the engagement is treated as a business-to-business arrangement. The contractor operates through their own limited company, invoices for services, and manages their own tax affairs including corporation tax, self-assessment, and VAT where applicable.

Outside IR35 engagements are assessed against three key factors: the degree of control the client exercises over how the work is delivered, whether the contractor has a genuine right to provide a substitute, and whether there is a mutuality of obligation between the parties. Contracts that demonstrate contractor autonomy, project-based delivery, and the absence of ongoing employment obligations are more likely to sit outside IR35. Since April 2021, responsibility for making this determination sits with the end client for medium and large private sector organisations.

On QualityContracts.co.uk, approximately 28% of roles with a stated IR35 status are classified as outside IR35. The proportion varies by sector and role type, with some disciplines seeing a significantly higher or lower share of outside IR35 opportunities. Each listing on this page displays its IR35 status where provided by the hiring organisation.

Pharmaceutical sector contracts can sit outside IR35 when structured around specific programme phases: managing a clinical trial stage, leading a regulatory submission, or conducting a manufacturing validation project. The milestone-driven nature of drug development creates natural engagement boundaries. CROs, pharmaceutical companies commissioning specific programme phases, and consultancies specialising in pharma and life sciences generate the strongest outside IR35 opportunities. GxP knowledge is a baseline requirement for most pharma contracting work.

Contract rates for pharma roles typically range from £450 to £800 per day, depending on the scope of the role, required expertise, and the delivery expectations of the engagement. Rates shown are for outside IR35 engagements and reflect the gross day rate paid to the contractor's limited company before any personal tax obligations.

Over the past twelve months, we have tracked over 60 pharma contract roles across the site. Of the roles currently listed on our site, around one in four are Outside IR35. Data reviewed up to June 2026.